Helix BioPharma Corp (HBPCF)
0.1377
0.00 (0.00%)
USD |
OTCM |
May 09, 16:00
Helix BioPharma Net Income (TTM): -4.401M for Oct. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| October 31, 2023 | -4.401M |
| July 31, 2023 | -4.684M |
| April 30, 2023 | -4.147M |
| January 31, 2023 | -4.222M |
| October 31, 2022 | -4.937M |
| July 31, 2022 | -5.172M |
| April 30, 2022 | -6.35M |
| January 31, 2022 | -7.316M |
| October 31, 2021 | -7.659M |
| July 31, 2021 | -6.386M |
| April 30, 2021 | -5.658M |
| January 31, 2021 | -5.442M |
| October 31, 2020 | -5.201M |
| July 31, 2020 | -6.679M |
| April 30, 2020 | -6.784M |
| January 31, 2020 | -6.527M |
| October 31, 2019 | -6.264M |
| July 31, 2019 | -5.677M |
| April 30, 2019 | -5.279M |
| January 31, 2019 | -5.410M |
| October 31, 2018 | -6.005M |
| July 31, 2018 | -6.788M |
| April 30, 2018 | -6.492M |
| January 31, 2018 | -6.996M |
| October 31, 2017 | -6.932M |
| Date | Value |
|---|---|
| July 31, 2017 | -7.599M |
| April 30, 2017 | -8.670M |
| January 31, 2017 | -8.167M |
| October 31, 2016 | -7.827M |
| July 31, 2016 | -7.287M |
| April 30, 2016 | -6.977M |
| January 31, 2016 | -6.748M |
| October 31, 2015 | -7.414M |
| July 31, 2015 | -7.368M |
| April 30, 2015 | -7.337M |
| January 31, 2015 | -7.787M |
| October 31, 2014 | -7.962M |
| July 31, 2014 | -8.098M |
| April 30, 2014 | -8.284M |
| January 31, 2014 | -8.563M |
| October 31, 2013 | -1.399M |
| July 31, 2013 | -1.445M |
| April 30, 2013 | -1.413M |
| January 31, 2013 | -2.109M |
| October 31, 2012 | -16.07M |
| July 31, 2012 | -17.20M |
| April 30, 2012 | -18.03M |
| January 31, 2012 | -18.11M |
| October 31, 2011 | -11.45M |
| July 31, 2011 | -11.70M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-7.659M
Minimum
Oct 2021
-4.147M
Maximum
Apr 2023
-5.750M
Average
-5.668M
Median
Net Income (TTM) Benchmarks
| Acasti Pharma Inc | -38.77M |
| Aurinia Pharmaceuticals Inc | -78.02M |
| Edesa Biotech Inc | -7.718M |
| Lexaria Bioscience Corp | -5.440M |
| Xenon Pharmaceuticals Inc | -182.39M |